Items where authors include "Gelderblom, H"

Article

Pantaleo, MA, Heinrich, MC, Italiano, A et al. (11 more authors) (2022) A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor. BMC Cancer, 22 (1). 511. 511-. ISSN 1471-2407

D’Ambrosio, L, Touati, N, Blay, J et al. (25 more authors) (2020) Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer, 126 (11). cncr.32795. pp. 2637-2647. ISSN 0008-543X

Schöffski, P, Wozniak, A, Kasper, B et al. (23 more authors) (2018) Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’. Annals of Oncology, 29 (3). pp. 758-765. ISSN 0923-7534

Marina, NM, Smeland, S, Bielack, SS et al. (50 more authors) (2016) Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncology, 17 (10). pp. 1396-1408. ISSN 1470-2045